Drug Type Small molecule drug |
Synonyms TER 1754 |
Target |
Action inhibitors |
Mechanism Akt-1 inhibitors(Serine/threonine-protein kinase AKT1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Telangiectasia, Hereditary Hemorrhagic | Phase 1 | United States | 15 Dec 2025 |





